Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Ambarella
AMBA
$3.77B
| $4.03M | ﹤0.01% |
39,279
-27,860
| -41% | -$2.44M |
|
|
ATHN
3127
CALL
DELISTED
Athenahealth, Inc.
ATHN
| $4.03M | ﹤0.01% |
35,200
+700
| +2% | +$83.7K |
|
|
GCE
3128
DELISTED
Claymore/Robb CEF GS Connect ETN
GCE
| $4.02M | ﹤0.01% |
238,716
+3,333
| +1% | +$58.6K |
|
|
ADVM
3129
PUT
DELISTED
Adverum Biotechnologies
ADVM
| $4.02M | ﹤0.01% |
+24,750
| New | +$8.35M |
|
3130
WisdomTree US High Dividend Fund
DHS
$1.56B
| $4.01M | ﹤0.01% |
67,474
-4,136
| -6% | -$253K |
|
3131
CALL
iShares MSCI South Korea ETF
EWY
$21.9B
| $4.01M | ﹤0.01% |
72,800
-122,700
| -63% | -$7.2M |
|
3132
Telecom Argentina
TEO
$6.03B
| $4.01M | ﹤0.01% |
222,682
+44,127
| +25% | +$907K |
|
3133
PUT
Ciena
CIEN
$53.4B
| $4M | ﹤0.01% |
169,000
-95,000
| -36% | -$2.17M |
|
3134
CALL
Scotiabank
BNS
$107B
| $4M | ﹤0.01% |
81,063
+9,955
| +14% | +$507K |
|
3135
iShares US Insurance ETF
IAK
$508M
| $4M | ﹤0.01% |
79,185
+2,044
| +3% | +$103K |
|
3136
Greif
GEF
$4.92B
| $3.99M | ﹤0.01% |
111,333
+8,169
| +8% | +$325K |
|
|
AMSG
3137
DELISTED
Amsurg Corp
AMSG
| $3.98M | ﹤0.01% |
56,975
-63,620
| -53% | -$4.25M |
|
|
BDSI
3138
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.98M | ﹤0.01% |
500,000
+423,700
| +555% | +$3.64M |
|
|
KYNB
3139
Kyntra Bio
KYNB
$27.2M
| $3.98M | ﹤0.01% |
6,770
-13,618
| -67% | -$7.92M |
|
3140
Quad
QUAD
$536M
| $3.97M | ﹤0.01% |
214,473
+86,831
| +68% | +$1.83M |
|
|
AEGN
3141
DELISTED
Aegion Corp
AEGN
| $3.97M | ﹤0.01% |
209,483
+34,920
| +20% | +$642K |
|
3142
Invesco Biotechnology & Genome ETF
PBE
$281M
| $3.97M | ﹤0.01% |
67,993
-1,569
| -2% | -$89.7K |
|
3143
CALL
DaVita
DVA
$15.4B
| $3.97M | ﹤0.01% |
49,900
+29,100
| +140% | +$2.39M |
|
|
CTRX
3144
PUT
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $3.96M | ﹤0.01% |
64,900
-35,500
| -35% | -$2.13M |
|
3145
Lands' End
LE
$370M
| $3.96M | ﹤0.01% |
159,578
+86,899
| +120% | +$2.5M |
|
3146
PUT
Canadian Solar
CSIQ
$1.02B
| $3.95M | ﹤0.01% |
138,200
-14,200
| -9% | -$487K |
|
3147
Gentherm
THRM
$1.25B
| $3.94M | ﹤0.01% |
71,853
-178,032
| -71% | -$9.44M |
|
|
PMCS
3148
DELISTED
P M C SIERRA INC
PMCS
| $3.94M | ﹤0.01% |
460,863
-613,924
| -57% | -$5.48M |
|
3149
Crocs
CROX
$6.14B
| $3.94M | ﹤0.01% |
268,043
+92,319
| +53% | +$1.31M |
|
3150
Hercules Capital
HTGC
$3.07B
| $3.93M | ﹤0.01% |
+340,435
| New | +$4.42M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.